Partnership with Highsmen Genetics is the right move in addition to Phylos Bioscience I believe. This combination will make it the most cost-effective way for patients to correlate their needs with a strain(Phylos) and then have it replicated as an actual product(Highsmen). All of this only possible beginning with MYDX. The power of the data achieved through this circuit boggles my mind. I believe MYDX, through its partnerships, will be the one stop shop for the masses and offer the best value on the market for achieving individual success, as opposed to a one size fits all shop that will prove not to be the wrong approach.
